11,340 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Bought by Centiva Capital LP

Centiva Capital LP purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 11,340 shares of the company's stock, valued at approximately $2,102,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Mutual of America Capital Management LLC raised its stake in shares of Inspire Medical Systems by 1.2% during the 4th quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company's stock worth $842,000 after purchasing an additional 55 shares during the period. Captrust Financial Advisors raised its position in Inspire Medical Systems by 2.0% in the fourth quarter. Captrust Financial Advisors now owns 3,034 shares of the company's stock worth $562,000 after acquiring an additional 59 shares during the period. MML Investors Services LLC boosted its stake in Inspire Medical Systems by 0.9% in the fourth quarter. MML Investors Services LLC now owns 7,941 shares of the company's stock valued at $1,472,000 after acquiring an additional 67 shares during the last quarter. Mariner LLC grew its position in shares of Inspire Medical Systems by 1.6% during the 4th quarter. Mariner LLC now owns 4,837 shares of the company's stock valued at $897,000 after acquiring an additional 77 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of Inspire Medical Systems by 1.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company's stock worth $1,461,000 after purchasing an additional 79 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company's stock.

Analysts Set New Price Targets

INSP has been the subject of several research reports. Royal Bank of Canada reduced their price objective on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Wells Fargo & Company decreased their price objective on Inspire Medical Systems from $195.00 to $174.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. KeyCorp lowered their price objective on Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Piper Sandler cut their target price on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Finally, Stifel Nicolaus lowered their price target on shares of Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Inspire Medical Systems currently has an average rating of "Moderate Buy" and an average price target of $211.91.

Insider Buying and Selling at Inspire Medical Systems

In other news, Director Shawn Mccormick sold 360 shares of the stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $160.00, for a total transaction of $57,600.00. Following the transaction, the director now directly owns 24,046 shares in the company, valued at approximately $3,847,360. This represents a 1.48 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Randy Ban sold 25,584 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the sale, the insider now owns 7,259 shares of the company's stock, valued at $1,332,026.50. The trade was a 77.90 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 26,527 shares of company stock worth $4,851,660 over the last 90 days. Corporate insiders own 4.10% of the company's stock.

Inspire Medical Systems Stock Performance

Inspire Medical Systems stock traded down $1.21 during midday trading on Friday, hitting $151.58. 309,473 shares of the company's stock were exchanged, compared to its average volume of 566,632. The stock has a 50-day moving average price of $157.70 and a two-hundred day moving average price of $178.21. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $225.00. The company has a market cap of $4.47 billion, a P/E ratio of 87.62, a PEG ratio of 2.86 and a beta of 1.39.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.33. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. The company had revenue of $201.32 million for the quarter, compared to analysts' expectations of $194.89 million. During the same period in the prior year, the business earned ($0.34) earnings per share. Inspire Medical Systems's revenue for the quarter was up 22.7% compared to the same quarter last year. As a group, sell-side analysts expect that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.